Literature DB >> 8425698

Inositol trisphosphate restores impaired human gallbladder motility associated with cholesterol stones.

J Behar1, B Y Rhim, W Thompson, P Biancani.   

Abstract

BACKGROUND: Gallbladder motility is impaired in specimens with cholesterol stones but normal with pigment stones.
METHODS: Muscle cells obtained from 19 human gallbladders with cholesterol stones and 11 with pigment stones were enzymatically digested and contracted with cholecystokinin octapeptide (CCK-8), acetylcholine, and KCl.
RESULTS: Muscle cells from pigment stones had a greater contraction than cells from cholesterol stones. CCK-8-induced contraction was unaffected by calcium-free media but was blocked by strontium. Potassium-evoked contraction was blocked by a calcium-free media and unaffected by strontium. Inositol triphosphate (IP-3)-induced contraction was similar to the contraction caused by CCK-8 in permeable cells from pigment stones but was greater than the response to CCK-8 in cells from cholesterol stones.
CONCLUSIONS: Muscle cells from gallbladders with cholesterol stones contract less than cells from gallbladders with pigment stones; CCK-8-induced contraction only uses stored calcium; and IP-3 causes contractions of equal magnitude in cells from gallbladders with cholesterol and pigment stones. These abnormalities could result from an impaired receptor activation of the mechanism for IP-3 generation and release of stored calcium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425698     DOI: 10.1016/0016-5085(93)90427-e

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease.

Authors:  B Lavoie; B Nausch; E A Zane; M R Leonard; O B Balemba; A C Bartoo; R Wilcox; M T Nelson; M C Carey; G M Mawe
Journal:  Neurogastroenterol Motil       Date:  2012-05-24       Impact factor: 3.598

2.  Differential effect of prostaglandins on gallstone-free and gallstone-containing human gallbladder.

Authors:  R R Greaves; L J O'Donnell; M J Farthing
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

3.  Effects of colectomy on gallbladder motility in patients with ulcerative colitis.

Authors:  A O Damião; A M Sipahi; D P Vezozzo; A L Gonçalves; A Habr-Gama; M G Teixeira; J T Fukushima; A A Laudanna
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

4.  Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones.

Authors:  Michele Pier Luca Guarino; Ping Cong; Michele Cicala; Rossana Alloni; Simone Carotti; Jose Behar
Journal:  Gut       Date:  2006-12-21       Impact factor: 23.059

5.  Gallbladder motor function, plasma cholecystokinin and cholecystokinin receptor of gallbladder in cholesterol stone patients.

Authors:  Jian Zhu; Tian-Quan Han; Sheng Chen; Yu Jiang; Sheng-Dao Zhang
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

6.  Effects of cholesterol on CCK-1 receptors and caveolin-3 proteins recycling in human gallbladder muscle.

Authors:  P Cong; V Pricolo; P Biancani; J Behar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-17       Impact factor: 4.052

Review 7.  Gallstones: an intestinal disease?

Authors:  K J Van Erpecum; G P Van Berge-Henegouwen
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

8.  Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis.

Authors:  David Q-H Wang; Frank Schmitz; Alan S Kopin; Martin C Carey
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 9.  Smooth muscle function and dysfunction in gallbladder disease.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gerard P vanBerge-Henegouwen
Journal:  Curr Gastroenterol Rep       Date:  2004-04

Review 10.  Structural basis of cholecystokinin receptor binding and regulation.

Authors:  Laurence J Miller; Fan Gao
Journal:  Pharmacol Ther       Date:  2008-05-11       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.